CAL-103

N/A

Report date: 2024/02/23 17:49:36

Base Information

Drug NameCAL-103
Drug Alias NameCAL-103CAL103
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionOxidized Phosphatidylcholine inhibitors
TargetsOxidized Phosphatidylcholine
Therapy Area/IndicationsInflammationFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCalluna Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesCalluna Pharma Inc
Inactive CompaniesN/A
Active IndicationsInflammationFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A